This product is for research use only, not for human use. We do not sell to patients.
| Size | Price | Stock |
|---|---|---|
| 1mg | $180 | To Be Confirmed |
| 5mg | $410 | To Be Confirmed |
| 10mg | $720 | To Be Confirmed |
: Cat #: V3539 CAS #: 892664-04-9 Purity ≥ 99%
Description: GSK-269984A is a novel and potent Prostaglandin E2 Receptor 1 (EP1) antagonist with a pIC50 of 7.9. GSK269984A was designed to overcome development issues encountered with previous EP(1) antagonists such as GW848687X and was found to display excellent activity in preclinical models of inflammatory pain. However, upon cross species pharmacokinetic profiling, GSK269984A was predicted to have suboptimal human pharmacokinetic and was thus progressed to a human microdose study.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
| Molecular Weight (MW) | 428.21632 |
|---|---|
| Molecular Formula | C20H13NO3FCL2-.NA+ |
| CAS No. | 892664-04-9 |
| Storage | Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Synonyms | GSK-269984A; GSK269984A; GSK 269984A |
| Solvent volume to be added | Mass (the weight of a compound) | |||
|---|---|---|---|---|
| Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
| 1mM | 2.3353 mL | 11.6763 mL | 23.3527 mL | 46.7054 mL |
| 5mM | 0.4671 mL | 2.3353 mL | 4.6705 mL | 9.3411 mL |
| 10mM | 0.2335 mL | 1.1676 mL | 2.3353 mL | 4.6705 mL |
| 20mM | 0.1168 mL | 0.5838 mL | 1.1676 mL | 2.3353 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.